STAGE IIIB BREAST CANCER AJCC V7
Clinical trials for STAGE IIIB BREAST CANCER AJCC V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB BREAST CANCER AJCC V7 trials appear
Sign up with your email to follow new studies for STAGE IIIB BREAST CANCER AJCC V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New gel aims to tame breast cancer before surgery
Disease control OngoingThis early-phase trial tests an endoxifen gel applied to the breast in 32 women scheduled for mastectomy. The goal is to find the safest dose and check for skin reactions. Endoxifen may help control or lower breast cancer risk, but this study focuses on side effects and drug leve…
Matched conditions: STAGE IIIB BREAST CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 23:23 UTC
-
Promising drug combo targets Hard-to-Treat breast cancer
Disease control OngoingThis early-stage trial tested the safety and best dose of two drugs—cyclophosphamide and veliparib—given together to people with HER2-negative breast cancer that has spread or cannot be removed by surgery. The goal was to find the right dose for future studies and see if the comb…
Matched conditions: STAGE IIIB BREAST CANCER AJCC V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
Immunotherapy drug shows promise for hard-to-treat cancers with genetic flaws
Disease control OngoingThis study tests the drug pembrolizumab in people with advanced solid tumors that have certain gene mutations (BRCA1, BRCA2, POLE, or POLD1). The goal is to see if the drug can shrink or control the cancer. About 21 adults with metastatic or recurrent cancer took part. Pembrolizu…
Matched conditions: STAGE IIIB BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New drug Z-Endoxifen takes on tamoxifen in breast cancer battle
Disease control OngoingThis study tests whether a newer drug, Z-Endoxifen, works better than the standard tamoxifen for postmenopausal women with advanced ER+/HER2- breast cancer. About 81 participants will receive one of the two hormone therapies to see which delays cancer growth longer. The goal is t…
Matched conditions: STAGE IIIB BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control OngoingThis study tests a combination of two drugs, cediranib and olaparib, in people with advanced solid tumors that have spread or can't be removed by surgery. The cancers include certain types of breast, lung, and pancreatic cancer. The goal is to see if the drug combo can shrink tum…
Matched conditions: STAGE IIIB BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 12, 2026 12:07 UTC
-
Can acupuncture ease pain in breast cancer survivors?
Symptom relief OngoingThis study looks at whether a type of acupuncture that uses mild electrical pulses can help reduce chronic pain in women who have finished treatment for early-stage breast cancer. About 111 women who have had pain for at least 3 months after surgery will be randomly assigned to r…
Matched conditions: STAGE IIIB BREAST CANCER AJCC V7
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 15, 2026 18:54 UTC